UBS O'Connor’s BIOMED REALTY TRUST INC BMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
Sell
-34,419
Closed -$666K 845
2015
Q2
$666K Sell
34,419
-7,352
-18% -$152K 0.01% 498
2015
Q1
$947K Buy
41,771
+27,312
+189% +$627K 0.02% 416
2014
Q4
$311K Buy
+14,459
New +$308K 0.01% 541
2014
Q3
Sell
-370,302
Closed -$8.08M 581
2014
Q2
$8.08M Sell
370,302
-1,369,698
-79% -$29.1M 0.05% 161
2014
Q1
$35.7M Buy
1,740,000
+619,999
+55% +$12.2M 0.68% 36
2013
Q4
$20.3M Buy
1,120,001
+350,003
+45% +$6.63M 0.37% 99
2013
Q3
$14.3M Buy
769,998
+67,225
+10% +$1.32M 0.3% 107
2013
Q2
$14.2M Buy
+702,773
New +$15.2M 0.27% 114

Other funds holding BMR

UBS O'Connor's BMR Position: Q3 2015 in Review

UBS O'Connor sold out of BIOMED REALTY TRUST INC (BMR) in Q3 2015, closing a stake of 34,419 shares — an estimated $666K sold.

UBS O'Connor first reported a position in BMR in Q2 2013 and held it in 8 quarters. The position peaked at $35.7M in Q1 2014. 283 funds tracked by Wall St. Rank hold BMR as of Q3 2015.

  • UBS O'Connor reported no remaining BIOMED REALTY TRUST INC position as of Q3 2015 after selling out during the quarter.
  • UBS O'Connor sold 34,419 BIOMED REALTY TRUST INC shares in Q3 2015, an estimated $666K.
  • UBS O'Connor first reported a position in BIOMED REALTY TRUST INC in Q2 2013 and held it in 8 quarters.
  • UBS O'Connor's BIOMED REALTY TRUST INC position peaked at $35.7M in Q1 2014.
  • 283 funds tracked by Wall St. Rank held BIOMED REALTY TRUST INC as of Q3 2015.

Based on UBS O'Connor's 13F filing for Q3 2015, filed 13 Nov 2015.